Literature DB >> 29045511

Mechanisms regulating T-cell infiltration and activity in solid tumors.

E Lanitis1, D Dangaj1, M Irving1, G Coukos1,2.   

Abstract

T-lymphocytes play a critical role in cancer immunity as evidenced by their presence in resected tumor samples derived from long-surviving patients, and impressive clinical responses to various immunotherapies that reinvigorate them. Indeed, tumors can upregulate a wide array of defense mechanisms, both direct and indirect, to suppress the ability of Tcells to reach the tumor bed and mount curative responses upon infiltration. In addition, patient and tumor genetics, previous antigenic experience, and the microbiome, are all important factors in shaping the T-cell repertoire and sensitivity to immunotherapy. Here, we review the mechanisms that regulate T-cell homing, infiltration, and activity within the solid tumor bed. Finally, we summarize different immunotherapies and combinatorial treatment strategies that enable the immune system to overcome barriers for enhanced tumor control and improved patient outcome.
© The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  T cells; cancer; immunotherapy; tumor microenvironment

Mesh:

Year:  2017        PMID: 29045511     DOI: 10.1093/annonc/mdx238

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  100 in total

Review 1.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

Authors:  Jackie E Bader; Kelsey Voss; Jeffrey C Rathmell
Journal:  Mol Cell       Date:  2020-06-18       Impact factor: 17.970

Review 2.  [Molecular predictors in immune oncology].

Authors:  W Weichert
Journal:  Pathologe       Date:  2018-11       Impact factor: 1.011

3.  An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors.

Authors:  Yong-Chen Lu; Zhili Zheng; Paul F Robbins; Eric Tran; Todd D Prickett; Jared J Gartner; Yong F Li; Satyajit Ray; Zulmarie Franco; Valery Bliskovsky; Peter C Fitzgerald; Steven A Rosenberg
Journal:  Mol Ther       Date:  2017-10-28       Impact factor: 11.454

Review 4.  CD8+ T cell states in human cancer: insights from single-cell analysis.

Authors:  Anne M van der Leun; Daniela S Thommen; Ton N Schumacher
Journal:  Nat Rev Cancer       Date:  2020-02-05       Impact factor: 60.716

5.  PHA eludes macrophage suppression to activate CD8+ T cells.

Authors:  Yelizavet D Lomakova; Jennifer Londregan; Jeffrey Maslanka; Naomi Goldman; John Somerville; James E Riggs
Journal:  Immunobiology       Date:  2018-11-03       Impact factor: 3.144

6.  Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma.

Authors:  So-Woon Kim; Young Il Kim; Bilal Mustafa; Mi-Ju Kim; Gowun Jeong; Sung-Min Ahn; Seok-Byung Lim; Chang Sik Yu; Jin Cheon Kim; Seung-Mo Hong; In Ja Park
Journal:  Mod Pathol       Date:  2020-07-24       Impact factor: 7.842

7.  Dawn of Chimeric Antigen Receptor T Cell Therapy in Non-Hodgkin Lymphoma.

Authors:  Karlo Perica; Lia Palomba; Renier J Brentjens
Journal:  Adv Cell Gene Ther       Date:  2018-10-07

Review 8.  Mechanisms of tumor immunotherapy, with a focus on thoracic cancers.

Authors:  Simona Ferro; Veronica Huber; Licia Rivoltini
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 9.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Authors:  Daniela Bruni; Helen K Angell; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2020-08-04       Impact factor: 60.716

10.  Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune Receptor.

Authors:  Nicholas G Minutolo; Prannda Sharma; Mathilde Poussin; Lauren C Shaw; Daniel P Brown; Erin E Hollander; Anže Smole; Alba Rodriguez-Garcia; James Z Hui; Fabiana Zappala; Andrew Tsourkas; Daniel J Powell
Journal:  J Am Chem Soc       Date:  2020-03-30       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.